Product Name
Nrf2 Recombinant Rabbit Monoclonal Antibody [PSH11-20] - BSA and Azide free
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human Nrf2 aa 51-350.
Target Molecular Weight
Predicted band size: 68 kDa
Positive Control
MEF treated with 10μM MG-132 for 8 hours cell lysate, HeLa treated with 2μM MG-132 for 18 hours cell lysate, C6 treated with 25μM MG-132 for 4 hours cell lysate, MEF cells treated with 2μM MG-132 for 18 hours, HCT 116 cells treated with 25μM MG-132 for 4 hours.
Storage Instructions
Store at 2-8℃. Avoid freeze.
Purification Method
Protein A affinity purified.
Function
Nuclear factor erythroid 2-related factor 2 (NRF2), also known as nuclear factor erythroid-derived 2-like 2, is a transcription factor that in humans is encoded by the NFE2L2 gene. NRF2 is a basic leucine zipper (bZIP) protein that may regulate the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation, according to preliminary research. In vitro, NRF2 binds to antioxidant response elements (AREs) in the promoter regions of genes encoding cytoprotective proteins. NRF2 induces the expression of heme oxygenase 1 in vitro leading to an increase in phase II enzymes. NRF2 also inhibits the NLRP3 inflammasome. NRF2 appears to participate in a complex regulatory network and performs a pleiotropic role in the regulation of metabolism, inflammation, autophagy, proteostasis, mitochondrial physiology, and immune responses. Several drugs that stimulate the NFE2L2 pathway are being studied for treatment of diseases that are caused by oxidative stress.
Background References
1. He F et al. NRF2, a Transcription Factor for Stress Response and Beyond. Int J Mol Sci. 2020 Jul
2. Ulasov AV et al. Nrf2/Keap1/ARE signaling: Towards specific regulation. Life Sci. 2022 Feb
Subcellular Location
Cytoplasm, cytosol, Nucleus.
Synonyms
erythroid derived 2 antibody
HEBP1 antibody
like 2 antibody
NF E2 related factor 2 antibody
NF-E2-related factor 2 antibody
NF2L2_HUMAN antibody
NFE2 related factor 2 antibody
NFE2-related factor 2 antibody
Nfe2l2 antibody
Nrf 2 antibody
Expand
erythroid derived 2 antibody
HEBP1 antibody
like 2 antibody
NF E2 related factor 2 antibody
NF-E2-related factor 2 antibody
NF2L2_HUMAN antibody
NFE2 related factor 2 antibody
NFE2-related factor 2 antibody
Nfe2l2 antibody
Nrf 2 antibody
NRF2 antibody
Nuclear factor (erythroid derived 2) like 2 antibody
Nuclear factor antibody
nuclear factor erythroid 2 like 2 antibody
Nuclear factor erythroid 2 related factor 2 antibody
Nuclear factor erythroid 2-related factor 2 antibody
Nuclear factor erythroid derived 2 like 2 antibody
Collapse
-
☑ Cell treatment (CT)
This data was developed using HA723302, the same antibody clone in a different buffer formulation.
Western blot analysis of Nrf2 on different lysates with Rabbit anti-Nrf2 antibody (HA723302) at 1/2,000 dilution.
Lane 1: MEF cell lysate
Lane 2: MEF treated with 10μM MG-132 for 8 hours cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 68 kDa
Observed band size: 100 kDa
Exposure time: 14 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723302) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Cell treatment (CT)
This data was developed using HA723302, the same antibody clone in a different buffer formulation.
Western blot analysis of Nrf2 on different lysates with Rabbit anti-Nrf2 antibody (HA723302) at 1/2,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: HeLa treated with 2μM MG-132 for 18 hours cell lysate
Lane 3: C6 cell lysate
Lane 4: C6 treated with 25μM MG-132 for 4 hours cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 68 kDa
Observed band size: 100 kDa
Exposure time: 2 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723302) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Cell treatment (CT)
This data was developed using HA723302, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of MEF cells untreated / treated with 2μM MG-132 for 18 hours labeling Nrf2 with Rabbit anti-Nrf2 antibody (HA723302) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Nrf2 antibody (HA723302) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
-
☑ Cell treatment (CT)
This data was developed using HA723302, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of HCT 116 cells untreated / treated with 25μM MG-132 for 4 hours labeling Nrf2 with Rabbit anti-Nrf2 antibody (HA723302) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Nrf2 antibody (HA723302) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
-
☑ Cell treatment (CT)
This data was developed using HA723302, the same antibody clone in a different buffer formulation.
Chromatin immunoprecipitations were performed with cross-linked chromatin from MEF cells treated with 10μM MG-132 for 8 hours with Nrf2 (HA723302) or Normal Rabbit IgG according to the ChIP protocol. The enriched DNA was quantified by real-time PCR using indicated primers. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"